CD274 and neoplasm: In fact, PD-L1 on the surface of tumor cells can enhance phagocytic capacity of PD-1 expressing TAMs [80], suggesting a positive contribution of this population in clinical outcomes of PD-1/PD-L1 blockade strategies.